Clinical Trial Update: A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System

View source ↗

Summary

This post-market clinical trial evaluating the performance and operation of the Brevera Breast Biopsy System has completed. Results were posted in December 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Brevera Breast Biopsy System (Brevera Breast Biopsy System)

Snippet

Sponsor: Hologic, Inc. | Conditions: Breast Cancer Female | Status: COMPLETED | Results posted: 2024-12-04